The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
<h4>Introduction</h4>Expression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems.<h4>Methods</h4>HER2 and HER3 overexpression/amplification were explored following internationally agreed guidelines using immunohistoc...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science (PLoS)
2018-01-01
|
| Edice: | PLoS ONE |
| On-line přístup: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0206007&type=printable |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
